| P2093 | author name string | Stefanie N Vogel | |
| | Jorge Blanco | |
| | Kari Ann Shirey | |
| | Dayanand Bagdure | |
| | Achsah D Keegan | |
| | Rose M Viscardi | |
| P2860 | cites work | Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran | Q24292781 |
| | Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo | Q24312071 |
| | Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function | Q24319020 |
| | Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma | Q24642215 |
| | CD14, endotoxin, and asthma risk: actions and interactions | Q24648536 |
| | Exploring the full spectrum of macrophage activation | Q24653754 |
| | Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease | Q26799132 |
| | Early childhood wheezers: identifying asthma in later life | Q26800269 |
| | Alternative activation of macrophages: an immunologic functional perspective | Q29614353 |
| | Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 |
| | Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 |
| | Pneumococcal pneumonia and influenza: a deadly combination | Q30227641 |
| | Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses | Q30303618 |
| | Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. | Q30367425 |
| | Exposure to environmental microorganisms and childhood asthma | Q31000265 |
| | Epithelium: at the interface of innate and adaptive immune responses | Q33605263 |
| | Macrophage activation state determines the response to rhinovirus infection in a mouse model of allergic asthma | Q33791469 |
| | The Joint Commission Children's Asthma Care quality measures and asthma readmissions | Q33819538 |
| | Macrophages: regulators of sex differences in asthma? | Q33868557 |
| | New drug targets for type 2 diabetes and the metabolic syndrome | Q34105009 |
| | Innate immune cell populations function as initiators and effectors in Th2 cytokine responses | Q34143992 |
| | Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation | Q34146922 |
| | Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. | Q34166520 |
| | PROPHYLACTIC ANTIBODY TREATMENT AND INTRAMUSCULAR IMMUNIZATION REDUCE INFECTIOUS HUMAN RHINOVIRUS 16 LOAD IN THE LOWER RESPIRATORY TRACT OF CHALLENGED COTTON RATS. | Q34349359 |
| | Agents that increase AAM differentiation blunt RSV-mediated lung pathology | Q34484085 |
| | Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist | Q34531671 |
| | The use of a neonatal mouse model to study respiratory syncytial virus infections | Q34549253 |
| | A chitinase-like protein in the lung and circulation of patients with severe asthma | Q34713773 |
| | Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults | Q35023114 |
| | Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. | Q35524932 |
| | Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza | Q35627060 |
| | Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years | Q45747463 |
| | Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy | Q45784299 |
| | Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls | Q45786507 |
| | Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life | Q47661621 |
| | Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments | Q47729166 |
| | Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation | Q47914659 |
| | Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response | Q47976088 |
| | Innate immune memory: a paradigm shift in understanding host defense. | Q50728169 |
| | Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5 | Q56287327 |
| | More alternative activation of macrophages in lungs of asthmatic patients | Q57891628 |
| | NK Cell Deficiency Predisposes to Viral-Induced Th2-Type Allergic Inflammation via Epithelial-Derived IL-25 | Q57966252 |
| | Interactions between Innate Antiviral and Atopic Immunoinflammatory Pathways Precipitate and Sustain Asthma Exacerbations in Children | Q58385251 |
| | Trends in childhood asthma: prevalence, health care utilization, and mortality | Q64127934 |
| | Status of childhood asthma in the United States, 1980-2007 | Q64132856 |
| | Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes | Q70466601 |
| | Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease | Q73269318 |
| | Siblings, day-care attendance, and the risk of asthma and wheezing during childhood | Q74212890 |
| | Trends in the cost of illness for asthma in the United States, 1985-1994 | Q74308240 |
| | Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages | Q84059121 |
| | Orchestrating house dust mite-associated allergy in the lung. | Q36054545 |
| | Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation | Q36062727 |
| | Innate immunological function of TH2 cells in vivo. | Q36074379 |
| | Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. | Q36157993 |
| | Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis | Q36225950 |
| | Protective immune mechanisms in helminth infection | Q36481763 |
| | Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development | Q36540154 |
| | Gene-environmental interaction in asthma | Q36706013 |
| | Community study of role of viral infections in exacerbations of asthma in 9-11 year old children | Q36903511 |
| | Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease | Q36955908 |
| | The TLR4 antagonist Eritoran protects mice from lethal influenza infection | Q37051987 |
| | Discovering susceptibility genes for asthma and allergy | Q37095239 |
| | Rhinovirus wheezing illness and genetic risk of childhood-onset asthma | Q37128812 |
| | PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. | Q37184395 |
| | Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis | Q37273123 |
| | Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. | Q37337400 |
| | Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen | Q37369842 |
| | Novel strategies for targeting innate immune responses to influenza. | Q37445698 |
| | Biology of lung dendritic cells at the origin of asthma | Q37600198 |
| | The role of respiratory virus infections in childhood asthma inception | Q37804518 |
| | Innate immunity in allergic disease | Q37891130 |
| | The sentinel role of the airway epithelium in asthma pathogenesis | Q37891138 |
| | Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. | Q37996251 |
| | The microbiology of asthma | Q38016314 |
| | Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsis | Q38334002 |
| | TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. | Q38363241 |
| | Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology. | Q38508568 |
| | Risk factors for asthma: is prevention possible? | Q38588853 |
| | Azithromycin alters macrophage phenotype | Q40019194 |
| | Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children | Q40308671 |
| | Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent | Q40734229 |
| | Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas | Q40749683 |
| | Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. | Q42602368 |
| | Genetic variants in the mannose receptor gene (MRC1) are associated with asthma in two independent populations | Q43245163 |
| | Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target | Q43804003 |
| | Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge | Q44078405 |
| | Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury | Q44231448 |
| | Influenza A facilitates sensitization to house dust mite in infant mice leading to an asthma phenotype in adulthood | Q44790523 |
| | Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. | Q45495234 |
| | Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. | Q45556830 |
| P433 | issue | 5 | |
| P577 | publication date | 2016-05-12 | |
| P1433 | published in | Pathogens and disease | Q27724629 |
| P1476 | title | Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link? | |
| P478 | volume | 74 | |